The US post-acute care industry, which deals with rehab and long-term care facilities, was worth an estimated $483 billion in ...

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from ...

On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Second patient death from liver failure after Sarepta's Elevidys gene therapy triggers FDA investigation. Stock crashes 41% ...

Simple steps can boost patient safety, including repeatedly asking patients for their name and birthdate to make sure you have the right patient at the right place. Monitoring statistics such as ...

The patient, who was being treated with an investigational gene therapy for limb-girdle muscular dystrophy, died of acute ...

Registered nurses at Ascension Saint Agnes Hospital in Baltimore are preparing to strike for the first time in the form of a ...

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, putting additional pressure on the biotech company after the recent deaths ...

Healthcare leaders can employ a range of strategies to ensure that patient safety is not compromised when care teams are ...

A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the ...

The National Medical Commission (NMC) has instructed medical colleges to form committees to monitor adverse events related to ...